>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

Hospital Drug Shortage Survey Mirrors Recent ASA Drug Shortage Survey

Thursday, July 14, 2011

The American Hospital Association (AHA) surveyed hospitals around the country to see the impact drug shortages were having on patient care. The results mirrored the results of the ASA drug shortage survey conducted in April 2011. 

The AHA survey found that 99.5 percent of hospitals were affected by drug shortages. In addition, the survey found that 95 percent of hospitals experienced a drug shortage impacting surgery/anesthesia. The survey also found that drug shortages resulted in patient treatment being delayed, a patient receiving a less effective drug, and a patient receiving an adverse outcome.

ASA continues to work closely with AHA and other organizations to address the serious issue of drug shortages. 

Click here to see more information on the ASA Drug Shortage Survey.

 

 

« Back to Washington Alerts